SU1496634A3 - Способ получени производных тиазолидиндиона или их натриевых солей - Google Patents

Способ получени производных тиазолидиндиона или их натриевых солей Download PDF

Info

Publication number
SU1496634A3
SU1496634A3 SU853966456A SU3966456A SU1496634A3 SU 1496634 A3 SU1496634 A3 SU 1496634A3 SU 853966456 A SU853966456 A SU 853966456A SU 3966456 A SU3966456 A SU 3966456A SU 1496634 A3 SU1496634 A3 SU 1496634A3
Authority
SU
USSR - Soviet Union
Prior art keywords
yes
joint venture
methanol
mid
ethanol
Prior art date
Application number
SU853966456A
Other languages
English (en)
Russian (ru)
Inventor
Мегуро Канадзи
Фудзита Такеси
Original Assignee
Такеда Кемикал Индастриз, Лтд (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Кемикал Индастриз, Лтд (Фирма) filed Critical Такеда Кемикал Индастриз, Лтд (Фирма)
Application granted granted Critical
Publication of SU1496634A3 publication Critical patent/SU1496634A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SU853966456A 1984-10-03 1985-10-02 Способ получени производных тиазолидиндиона или их натриевых солей SU1496634A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1984/000466 WO1986002073A1 (fr) 1984-10-03 1984-10-03 Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
SU1496634A3 true SU1496634A3 (ru) 1989-07-23

Family

ID=13818418

Family Applications (1)

Application Number Title Priority Date Filing Date
SU853966456A SU1496634A3 (ru) 1984-10-03 1985-10-02 Способ получени производных тиазолидиндиона или их натриевых солей

Country Status (4)

Country Link
HU (1) HU194199B (fr)
SU (1) SU1496634A3 (fr)
WO (1) WO1986002073A1 (fr)
ZA (1) ZA857448B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
MX356584B (es) 2006-03-16 2018-06-05 Metabolic Solutions Dev Co Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
CA2646149A1 (fr) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Analogues de thiazolidinedione
EP2203433B1 (fr) 2007-09-14 2012-10-31 Metabolic Solutions Development Company LLC 5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione pour le traitement de la diabète
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
ES2658168T3 (es) 2009-12-15 2018-03-08 Cirius Therapeutics, Inc. Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
JPS5948471A (ja) * 1982-09-10 1984-03-19 Takeda Chem Ind Ltd チアゾリジン誘導体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
За вка JP № 22636-80, кл, С 07 D 417/12, 1982. Diabetes, 32, 804, 1983. *

Also Published As

Publication number Publication date
HU194199B (en) 1988-01-28
HUT39439A (en) 1986-09-29
WO1986002073A1 (fr) 1986-04-10
ZA857448B (en) 1987-05-27

Similar Documents

Publication Publication Date Title
US4725610A (en) Thiazolidinedione derivatives, their production and use
CA1277323C (fr) Derives de thiazolidinedione, leur production et leur emploi
RU2129553C1 (ru) Производные тиазолидиндиона, их получение и фармацевтическая композиция
US4476137A (en) [1-(2-Benzoxazolyl)hydrazino]alkyl nitrile derivatives
CA1128947A (fr) 5-(4-pyridyl)-6-(4-fluorophenyl)-2,3- dihydroimidazo ¬2,1-b| thiazole
CA2242632A1 (fr) Utilisation d'un antagoniste de ppar-alpha et de ppar-gamma dans le traitement du syndrome x
WO1994029285A1 (fr) Derives heterocycliques et leur utilisation dans des produits pharmaceutiques
WO1994013650A1 (fr) Derives heterocycliques et leur utilisation comme produits pharmaceutiques
AU8317891A (en) Oxazolidine dione derivatives
WO1997000868A1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
EP0934290B1 (fr) Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
SK164598A3 (en) 5-phenoxyalkyl-2,4-thiazolidinedione derivative, method for the preparaton thereof, intermediate products for its preparation and pharmaceutical composition containing same
SU1496634A3 (ru) Способ получени производных тиазолидиндиона или их натриевых солей
EP1142885B1 (fr) Derives de 2-(n-cyano-imino)thiazolidin-4-one
EP0033617A2 (fr) Dérivés de la thiazolidine, leur préparation et médicaments les contenant
JPH0592960A (ja) チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
EP0173520A2 (fr) Oxindoles tricycliques comme agents anti-inflammatoires
EP0006368A1 (fr) Dérivés de phényl-4 thiazolyl-2 oxamate, procédé pour leur préparation et leur application dans le traitement de l'asthme
WO2008006626A1 (fr) Hétérocycles à 5 chaînons modifiés par trois noyaux phényle et leur utilisation en tant qu'agents anticancéreux et anti-inflammatoires
JPS6058981A (ja) 5−ピリジル−1,3−チアゾ−ル誘導体,その製造法およびそれを含んでなる医薬組成物
US5300518A (en) Pyridyl substituted benzothiazole compounds which have useful pharmaceutical utility
EP0099770B1 (fr) Nouveaux dérivés d'oxazinobenzothiazine-6,6-dioxyde, leur préparation et leur application en tant que médicaments
JPH0613515B2 (ja) ピラゾロ〔1,5−a〕ピリジン誘導体及びそれを含有する治療剤
RU2041216C1 (ru) Производное бензотиазола или его фармакологически приемлемая соль
JPH0680041B2 (ja) 2−ピリジル酢酸誘導体、その製法およびそれを含む医薬